- Home
- PRME vs BSX Comparison
PRME vs BSX Comparison
Compare PRME & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- BSX
- Stock Information
- Founded
- PRME 2019
- BSX 1979
- Country
- PRME United States
- BSX United States
- Employees
- PRME N/A
- BSX N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- BSX Medical/Dental Instruments
- Sector
- PRME Health Care
- BSX Health Care
- Exchange
- PRME Nasdaq
- BSX Nasdaq
- Market Cap
- PRME 191.7M
- BSX 138.4B
- IPO Year
- PRME 2022
- BSX 1992
- Fundamental
- Price
- PRME $4.27
- BSX $103.19
- Analyst Decision
- PRME Buy
- BSX Strong Buy
- Analyst Count
- PRME 6
- BSX 22
- Target Price
- PRME $9.38
- BSX $112.86
- AVG Volume (30 Days)
- PRME 5.0M
- BSX 7.4M
- Earning Date
- PRME 08-04-2025
- BSX 07-23-2025
- Dividend Yield
- PRME N/A
- BSX N/A
- EPS Growth
- PRME N/A
- BSX 15.23
- EPS
- PRME N/A
- BSX 1.37
- Revenue
- PRME $3,846,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- PRME $104.12
- BSX $17.50
- Revenue Next Year
- PRME $108.24
- BSX $10.75
- P/E Ratio
- PRME N/A
- BSX $75.30
- Revenue Growth
- PRME 550.76
- BSX 19.36
- 52 Week Low
- PRME $1.11
- BSX $71.88
- 52 Week High
- PRME $6.75
- BSX $107.53
- Technical
- Relative Strength Index (RSI)
- PRME 80.29
- BSX 49.67
- Support Level
- PRME $2.28
- BSX $101.56
- Resistance Level
- PRME $4.83
- BSX $104.41
- Average True Range (ATR)
- PRME 0.46
- BSX 1.83
- MACD
- PRME 0.21
- BSX -0.11
- Stochastic Oscillator
- PRME 84.52
- BSX 34.54
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.